Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€64.80
23.02.24
€79.43
23.02.25
-0.46%
05.07.24

Royal Bank of Canada 
23.02.24 50%
buy
Dynavax Technologies Corp

Start price
Target price
Perf. (%)
€11.79
23.02.24
-
23.02.25
-13.66%
03.07.24

William Blair 
23.02.24 50%
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€63.50
23.02.24
€75.68
23.02.25
1.57%
05.07.24

Needham & Company LLC 
23.02.24 50%
buy
Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€1.24
22.02.24
€13.86
22.02.25
-40.08%
26.06.24

HC Wainwright 
22.02.24 50%
buy
Rhythm Pharmaceuticals

Start price
Target price
Perf. (%)
€41.40
22.02.24
€46.19
22.02.25
-8.70%
04.07.24

Needham & Company LLC 
22.02.24 50%
buy
Galmed Pharmaceuticals Ltd.

Start price
Target price
Perf. (%)
€0.34
21.02.24
€59.19
21.02.25
-21.18%
04.07.24

Stifel Nicolaus 
21.02.24 50%
buy
AnaptysBio Inc

Start price
Target price
Perf. (%)
€23.40
21.02.24
€46.24
21.02.25
-2.56%
04.07.24

Stifel Nicolaus 
21.02.24 50%
buy
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.08
21.02.24
-
21.02.25
-72.28%
05.07.24

Fitzi 
21.02.24 0%
buy
Prothena Corp. plc

Start price
Target price
Perf. (%)
€25.20
20.02.24
€73.90
20.02.25
-27.38%
05.07.24

Oppenheimer Holdings Inc. 
20.02.24 50%
sell
Daiichi Sankyo Co Ltd

Start price
Target price
Perf. (%)
€30.99
20.02.24
-
20.02.27
6.75%
05.07.24

robertinio 
20.02.24 100%
buy
Fagron N.V.

Start price
Target price
Perf. (%)
€18.31
19.02.24
€20.00
19.02.25
0.82%
05.07.24

melinda 
19.02.24 20%
sell
Novan Inc

Start price
Target price
Perf. (%)
€0.001
19.02.24
-
19.02.25
-
19.09.23

StockNews.com 
19.02.24 50%
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€69.40
19.02.24
€85.00
30.09.25
-8.50%
05.07.24

Could be very worthwhile Investment >20% year
BiotechBee 
19.02.24 70%
sell
Trevena Inc.

Start price
Target price
Perf. (%)
€0.51
18.02.24
-
18.02.25
-61.49%
04.07.24

StockNews.com 
18.02.24 50%
sell
Atara Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€0.70
18.02.24
-
18.02.25
-47.29%
18.06.24

ReynadJ 
18.02.24 0%
buy
Atara Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€0.70
18.02.24
-
18.02.25
-47.29%
18.06.24

collins 
18.02.24 0%
sell
Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.22
18.02.24
-
18.02.25
-37.65%
05.07.24

goldmanns 
18.02.24 0%
sell
Coherus Bioscien.

Start price
Target price
Perf. (%)
€2.52
18.02.24
-
18.02.25
-49.64%
05.07.24

goldmanns 
18.02.24 0%
buy
Ardelyx Inc.

Start price
Target price
Perf. (%)
€8.30
17.02.24
€11.00
31.01.26
-41.16%
05.07.24

Could be very worthwhile Investment >20% year
BiotechBee 
17.02.24 80%
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€69.30
17.02.24
€76.07
17.02.25
-8.37%
05.07.24

Mizuho 
17.02.24 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€26.60
17.02.24
€36.18
17.02.25
-70.54%
05.07.24

Mizuho 
17.02.24 50%
sell
Cara Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.54
17.02.24
-
17.02.25
-59.93%
28.06.24

StockNews.com 
17.02.24 50%
buy
Corcept Therapeutics Inc.

Start price
Target price
Perf. (%)
€21.00
17.02.24
-
17.02.25
35.33%
03.07.24

StockNews.com 
17.02.24 50%
sell
Durect Corp.

Start price
Target price
Perf. (%)
€0.37
17.02.24
-
17.02.25
-
05.12.22

StockNews.com 
17.02.24 50%
buy
TG Therapeutics Inc.

Start price
Target price
Perf. (%)
€12.69
17.02.24
-
17.02.25
35.29%
05.07.24

StockNews.com 
17.02.24 50%